| Pleuroperitoneal migration of intraperitoneal phosphorus-32-chromic phosphate therapy for stage I ovarian carcinoma. | |
| | |
MedLine Citation:
|
PMID: 8691256 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A patient with postoperative Stage I ovarian carcinoma received 15 mCi of 32P-chromic phosphate suspension in normal saline intraperitoneally as part of her therapy. The following day, a portion of the infused radiopharmaceutical and normal saline had passed transdiaphragmatically into the patient's right pleural cavity. Thoracentesis removed as much fluid as possible and this fluid contained radioactive material. In the ensuing 4 yr, the patient has not manifested any detectable pleural or pulmonary abnormalities attributable to the radioactivity. Retrospective review of 100 consecutive patients receiving 32P-chromic phosphate intraperitoneal therapy resulted in 43 patients in whom the hemithoraces could be evaluated scintigraphically. Three of the 43 patients (7%) had right pleural fluid radioactivity. This is similar to the percentages reported in patients with cirrhosis with ascites in whom hepatic hydrothorax is identified. |
| | |
Authors:
|
R H Wilkinson |
Related Documents
:
|
7224356 - Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical s... 15947326 - Thoracentesis in patients with hematologic malignancy: yield and safety. 9306506 - Predicting respiratory failure in sarcoidosis patients. 18087126 - Interstitial and glomerular renal involvement in sarcoidosis. 17130736 - Enterobius vermicularis and colitis in children. 11033756 - Primary hyperparathyroidism. when to observe and when to operate. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of nuclear medicine : official publication, Society of Nuclear Medicine Volume: 37 ISSN: 0161-5505 ISO Abbreviation: J. Nucl. Med. Publication Date: 1996 Apr |
Date Detail:
|
Created Date: 1996-08-26 Completed Date: 1996-08-26 Revised Date: 2006-04-11 |
Medline Journal Info:
|
Nlm Unique ID: 0217410 Medline TA: J Nucl Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 636-9 Citation Subset: IM |
Affiliation:
|
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Chromium Compounds
/
administration & dosage,
pharmacokinetics,
therapeutic use* Extravasation of Diagnostic and Therapeutic Materials / diagnosis, etiology* Female Humans Infusions, Parenteral Middle Aged Ovarian Neoplasms / radiotherapy* Peritoneal Cavity Phosphates / administration & dosage, pharmacokinetics, therapeutic use* Phosphorus Radioisotopes / administration & dosage, pharmacokinetics, therapeutic use* Pleura Pleural Effusion / diagnosis, etiology* Technetium Tc 99m Sulfur Colloid / diagnostic use Time Factors Tissue Distribution |
| Chemical | |
Reg. No./Substance:
|
0/Chromium Compounds; 0/Phosphates; 0/Phosphorus Radioisotopes; 0/Technetium Tc 99m Sulfur Colloid; 7789-04-0/chromic phosphate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Disseminated bone marrow metastases of insular thyroid carcinoma detected by radioiodine whole-body ...
Next Document: Intestinal leakage of technetium-99m-MDP in primary intestinal lymphangiectasia.